What is Pacira BioSciences, Inc.'s total revenue?

Pacira BioSciences, Inc. (PCRX) reported total revenue of $177.38M in Q1 2026.

How has Pacira BioSciences, Inc.'s total revenue changed year-over-year?

Pacira BioSciences, Inc.'s total revenue increased by 5.0% year-over-year, from $168.92M to $177.38M.

What is the long-term trend for Pacira BioSciences, Inc.'s total revenue?

Over 4 years (2021 to 2025), Pacira BioSciences, Inc.'s total revenue has grown at a 7.6% compound annual growth rate (CAGR), from $541.53M to $726.41M.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Pacira BioSciences, Inc. PCRX Total Revenue

Total Revenue at other companies

Avanos MedicalAVNS

$182.2M+8.8%

Collegium Pharmaceutical, Inc.COLL

$193.52M+8.9%

Segments

By product

See full

EXPAREL$143.27M+4.9%

ZILRETTA$26.77M+14.7%

iovera°$6.18M+20.6%

Bupivacaine liposome injectable suspension$1.16M-55.5%

By segment

See full

Reportable Segment$177.38M+5.0%

Other financials

Income statement

See full

Gross profit$141.0M+4.7%

Operating income$6.9M+247%

Net income$2.9M-39.4%

EPS (diluted)$0.07-30.0%

Balance sheet

See full

Cash & equivalents$144.3M-49.1%

Total debt$411.2M+15.3%

Total equity$653.9M-18.1%

Total assets$1.2B-23.8%

Cash flow

See full

Operating cash flow$25.7M-27.6%

CapEx$2.7M-68.1%

Free cash flow$23.0M-14.7%

Valuation

See full

Market cap$942.78M-16.0%

Enterprise value$1.21B+1.2%

P/E183.5×—

P/S1.3×-0.3×

Profitability

See full

Gross margin79.3%+1.7pp

Operating margin3.3%—

Net margin0.7%—

FCF margin18.1%-4.6pp

Returns & leverage

See full

Return on equity0.7%—

Debt / equity0.6×+0.2×

Current ratio4.7×+2.3×

Where this comes from

Reported directly by Pacira BioSciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pacira BioSciences, Inc.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Pacira BioSciences, Inc.'s total revenue?: Pacira BioSciences, Inc. (PCRX) reported total revenue of $177.38M in Q1 2026.
How has Pacira BioSciences, Inc.'s total revenue changed year-over-year?: Pacira BioSciences, Inc.'s total revenue increased by 5.0% year-over-year, from $168.92M to $177.38M.
What is the long-term trend for Pacira BioSciences, Inc.'s total revenue?: Over 4 years (2021 to 2025), Pacira BioSciences, Inc.'s total revenue has grown at a 7.6% compound annual growth rate (CAGR), from $541.53M to $726.41M.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.